Molina J-M, et al. Doravirine (DOR) versus ritonavir-boosted darunavir (DRV+r): 96-week results of the randomized, double-blind, phase 3 DRIVE-FORWARD Noninferiority trial. AIDS 2018.
Benralizumab, dupilumab of mepolizumab: lagere SARS-CoV-2-immuniteit na vaccinatie
okt 2024 | Astma, Eczeem, Vaccinatie, Virale infecties